REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Chelidonium Kft (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Chelidonium Gyogyaszati es Ingatlanhasznosito Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Chelidonium Kft is based in Hungary. The head office is in Nagykanizsa. The company operates in the Pharmacies and Drug Stores sector. Chelidonium Kft was incorporated on November 25, 2011. There are currently 4 (2024) people employed by Chelidonium Kft. From the latest financial highlights, Chelidonium Kft reported a net sales revenue increase of 10.08% in 2023. Its total assets grew by 15.13% over the same period. In 2023, Chelidonium Kft’s net profit margin decreased by 1.62%.

Headquarters
Garay utca 12-14. F. lhaz. fszt. 1.
Nagykanizsa; Zala; Postal Code: 8800

Contact Details: Purchase the Chelidonium Kft report to view the information.

Basic Information
Total Employees:
Purchase the Chelidonium Kft report to view the information.
Outstanding Shares:
Purchase the Chelidonium Kft report to view the information.
Registered Capital:
Purchase the Chelidonium Kft report to view the information.
Incorporation Date:
November 25, 2011
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Chelidonium Kft report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.08%▲
Total operating revenue
9.83%▲
Operating profit (EBIT)
-20.55%▼
EBITDA
-16.51%▼
Net Profit (Loss) for the Period
-32.94%▼
Total assets
15.13%▲
Total equity
-26.69%▼
Operating Profit Margin (ROS)
-1.41%▼
Net Profit Margin
-1.62%▼
Return on Equity (ROE)
-4.26%▼
Quick Ratio
-0.02%▼
Cash Ratio
-0.08%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo